Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats

Journal of Hypertension

Volumn 20, Issue 7, 2002, Pages 1407-1412

  El Midaoui, Adil ^a   Wu, Rong ^a   De Champlain, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Aspirin; Hypertension; Insulin resistance; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; WATER; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CHEMOLUMINESCENCE; CHRONOPHARMACOLOGY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ENZYME ACTIVITY; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HYPERGLYCEMIA; HYPERTENSION; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BIOLOGICAL MODEL; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CANADA; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EVALUATION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYSTOLE; TIME; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; ASPIRIN; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CANADA; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GLUCOSE; GLUTATHIONE PEROXIDASE; HYPERGLYCEMIA; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MODELS, CARDIOVASCULAR; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; SUPEROXIDES; SYSTOLE; TIME FACTORS;

EID: 0036628762     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200207000-00028     Document Type: Article

References (27)

1. Oxidative stress and diabetic vascular complications
2. Enhanced superoxide anion formation in vascular tissues from SHR and DOCA-salt hypertensive rats
3. Anti-oxidant status and lipid peroxidation in patients with essential hypertension
4. Update on aspirin in the treatment and prevention of cardiovascular disease
5. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
6. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
7. Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man
8. Role of oxidative stress in cardiovascular diseases
9. Oxygen-derived radicals: A link between reperfusion injury and inflammation
10. The pathogenesis of atherosclerosis: A perspective for the 1990s
11. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
12. The prostaglandin paradox: Additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol
13. Effects of non-steroidal anti-inflammatory drugs on human neutrophil NADPH oxidase in both whole cell and cell-free systems
14. Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats
15. Prevention of hypertension, insulin resistance and oxidative stress by α-lipoic acid
16. Gluthatione peroxidase: Activity and steady-state level of mRNA
17. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
18. Therapeutic index for rosiglitazone in dietary obese rats: Separation of efficacy and haemodilution
19. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance
20. Hypercholesterolemia increases endothelial superoxide anion production
21. Oxidative glycation and free radical production: A causal mechanism of diabetic complications
22. Preventive aspirin treatment of streptozotocin induced diabetes: Blockage of oxidative status and revertion of heme enzymes inhibition
23. Inflammation and coronary artery disease
24. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta
25. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension
26. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone
27. Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats